IMDX
Insight Molecular Diagnostics
IMDX
IMDX
26 hedge funds and large institutions have $53.9M invested in Insight Molecular Diagnostics in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less funds holding
Funds holding: 30 → 26 (-4)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
26
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.08M | |
| 2 | +$185K | |
| 3 | +$136K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$74K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$34.6K |
Top Sellers
| 1 | -$99.4K | |
| 2 | -$63.5K | |
| 3 | -$42K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$35.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12.8K |
